Neuropharmacology Research
Neuropharmacology Research - Related Videos
09:46
A Pressure Injection System for Investigating the Neuropharmacology of Information Processing in Awake Behaving Macaque Monkey Cortex
0 Views •
Cited by 3 •
2016
Here, we show the pressure injection of neuropharmacological substances during single-cell recording in an awake, behaving macaque monkey. This procedure allows pharmacological manipulation in the direct vicinity of a cortical recording site.
11:08
Neuropharmacological Manipulation of Restrained and Free-flying Honey Bees, Apis mellifera
0 Views •
Cited by 13 •
2016
This manuscript describes several protocols for administering pharmacological agents to honey bees, including simple noninvasive methods for free-flying bees, as well as more invasive variants that allow precise localized treatment of restrained bees.
08:04
Cytotoxic Efficacy of Photodynamic Therapy in Osteosarcoma Cells In Vitro
0 Views •
Cited by 8 •
2014
The protocol reported here allows the evaluation of the efficacy of photodynamic therapy (PDT) in cell lines and the optimization of the PDT settings before applying the therapy in animal models.
09:39
An Open-Source, Fully Customizable 5-Choice Serial Reaction Time Task Toolbox for Automated Behavioral Training of Rodents
0 Views •
Cited by 1 •
2022
The present protocol describes the development of an open-source 5-choice serial reaction time task toolbox for rodent animal models, using Arduino and related hardware and a versatile Matlab toolbox, including an optional script for automated behavioral training. The scripts are customizable and facilitate the implementation of different trial-and-test designs.
10:01
Structure-Guided Design and Development of Novel Cyclophilin A Inhibitors and Ganoderiol-F Derivatives: An In-Silico Approach
0 Views •
2026
Here, we present a protocol for the structure-guided design of protein-ligand binding interaction between Sanglifehrin A and Cyclophilin A/Ganoderiol-F, essential in discovering new drugs. The stability of the ligand-receptor complex was evaluated using molecular dynamics simulation.
FAQs
A chemical agent can activate or inhibit a receptor, changing the signals passed within neurons and neural circuits. These receptor-level effects may influence neurotransmitter release, ion-channel activity, or broader cellular signaling. By connecting those molecular changes with alterations in neural function and behavior, researchers can identify mechanisms that may contribute to neurological or psychiatric conditions and reveal potential therapeutic targets.
Neurotransmitter release controls how neurons communicate, while ion-channel modulation changes how neural cells respond to signals. Examining both mechanisms helps distinguish how chemical agents influence nervous-system activity at the cellular level. This information is especially relevant when investigating treatments for conditions such as epilepsy, pain, depression, or Parkinson’s disease, because different mechanisms may produce different functional outcomes.
The field links several levels of analysis, beginning with interactions between drugs or other chemical agents and molecular targets, then tracing effects through neurons and brain circuits to changes in behavior. This multilevel approach helps explain how a biological action can become a functional or behavioral outcome. It also supports more precise efforts to understand disorders and restore neural function.
Neuropharmacology research draws on cellular, animal, and human studies, with each level contributing different information about neural effects and treatment outcomes. Cellular work can clarify molecular and neuronal mechanisms, whereas animal and human studies extend those findings to broader neural function, behavior, or treatment evaluation. Considering these levels together supports safer and more informative drug development.
Researchers examine how altered signaling, receptor activity, neurotransmitter release, ion channels, and related cellular pathways affect neural function and behavior. Connecting these changes with disorders such as epilepsy, depression, Parkinson’s disease, or pain can highlight biological processes suitable for therapeutic targeting. Subsequent treatment evaluation helps determine whether influencing those processes may support improved or restored neural function.
Studying drug effects across molecular, cellular, circuit, behavioral, and human levels can reveal both therapeutic actions and how treatments influence the nervous system more broadly. This evidence supports safer drug development and helps refine approaches aimed at particular neural mechanisms or conditions. In neuroscience, such work contributes to more precise strategies for treating neurological and psychiatric disorders while evaluating treatment effects.